# A bispecific antibody targeting GPC3 and CD47 induced enhanced antitumor efficacy against dual antigen-expressing HCC

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/a-bispecific-antibody-targeting-gpc3-and-cd47-induced-enhanced-antitumor/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Kaixin Du,Yulu Li,Juan Liu,Wei Chen,Zhizhong Wei,Yong Luo,Huisi Liu,Yonghe Qi,Fengchao Wang,Jianhua Sui |
| Citations | 104 |
| DOI | 10.1016/j.ymthe.2021.01.006 |
| Fields | Immunology and Microbiology,Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | http://www.cell.com/article/S152500162100006X/pdf |
| OpenAlex ID | https://openalex.org/W3157188545 |
| PMID | 33429083 |
| Type | article |
| Year | 2021 |

## Paper authors

- [Yulu Li](https://scholariq.org/researchers/yulu-li/)

## Paper primary topic

- [Phagocytosis and Immune Regulation](https://scholariq.org/topics/phagocytosis-and-immune-regulation/)

## Paper topics

- [Phagocytosis and Immune Regulation](https://scholariq.org/topics/phagocytosis-and-immune-regulation/)
- [Erythrocyte Function and Pathophysiology](https://scholariq.org/topics/erythrocyte-function-and-pathophysiology/)
- [Immunotherapy and Immune Responses](https://scholariq.org/topics/immunotherapy-and-immune-responses/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.